ORZEYFUL (oveporexton) Approved in Japan as the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 1

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. HUVR:IN
2. ANET
3. NKE
4. PANW
5. CL
6. SNDK
7. TAP
8. DELL
9. ROIV
10. BAC

Go back to ORZEYFUL (oveporexton) Approved in Japan as the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 1
(NYSE: TAK) Delayed: 18.45 -0.26 (1.39%)
Previous Close $18.71    52 Week High $0.55 
Open $18.48    52 Week Low $0.55 
Day High $18.54    P/E N/A 
Day Low $18.39    EPS $-0.20 
Volume 1,499,548